Abstract
Objective
To determine the feasibility and safety of image-guided brachytherapy employing a modified open high-field MR system.
Methods
This is a follow-up study of a development project enabling technologies for interventional use of 1.0T open MRI. Modifications included coils and in-bore visualization, fluoroscopic sequences and user interfaces. We recruited 104 patients with 224 liver malignancies to receive MR-guided brachytherapy. Interventions were performed >20 min after Gd-EOB-DTPA. We recorded interventional parameters including the intervention time (from acquisition of the first scout until the final sequence for brachytherapy treatment planning). Two reviewers assessed MR-fluoroscopic images in comparison to plain CT as used in CT intervention, applying a rating scale of 1–10. Statistical analysis included Friedman and Kendall’s W tests.
Results
We employed freehand puncture with interactive dynamic imaging for navigation. Technical success rate was 218 complete ablations in 224 tumours (97%). The median intervention time was 61 min. We recorded no adverse events related to the use of MRI. No major complications occurred. The rate of minor complications was 4%. Local control at 3 months was 96%. Superiority of MR-fluoroscopic, Gd-EOB-DTPA-enhanced images over plain CT was highly significant (P < 0.001).
Conclusion
MR-guided brachytherapy employing open high-field MRI is feasible and safe.
Similar content being viewed by others
References
Goldberg SN, Grassi CJ, Cardella JF et al (2005) Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 16:765–778
Xiao YY, Tian JL, Li JK et al (2008) CT-guided percutaneous chemical ablation of adrenal neoplasms. AJR Am J Roentgenol 190:105–110
Gillams AR, Lees WR (2008) Radiofrequency ablation of lung metastases: factors influencing success. Eur Radiol 18(4):672–677
Curley SA (2008) Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? Ann Surg Oncol 15:11–13
Zhang YJ, Liang HH, Chen MS et al (2007) Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial. Radiology 244:599–607
Vogl TJ, Straub R, Eichler K et al (2004) Colorectal carcinoma metastases in liver: laser-induced interstitial thermotherapy-local tumor control rate and survival data. Radiology 230:450–458
Pech M, Mohnike K, Wieners G, Bialek E, Dudeck O, Seidensticker M, Peters N, Wust P, Gademann G, Ricke J (2008) Radiotherapy of liver metastases. Comparison of target volumes and dose-volume histograms employing CT- or MRI-based treatment planning. Strahlenther Onkol 184:256–261
Mast TD, Pucke DP, Subramanian SE, Bowlus WJ, Rudich SM, Buell JF (2008) Ultrasound monitoring of in vitro radio frequency ablation by echo decorrelation imaging. J Ultrasound Med 27:1685–1697
Stroszczynski C, Gaffke G (2006) Use of imaging modalities for the guidance of minimally invasive tumor therapies (MITT). Recent Results Cancer Res 167:3–12
Nakai M, Sato M, Sahara S, Takasaka I, Kawai N, Minamiguchi H, Tanihata H, Kimura M, Takeuchi N (2009) Radiofrequency ablation assisted by real-time virtual sonography and CT for hepatocellular carcinoma undetectable by conventional sonography. Cardiovasc Intervent Radiol 32:62–69
Laganà D, Carrafiello G, Mangini M, Lumia D, Mocciardini L, Chini C, Pinotti G, Cuffari S, Fugazzola C (2008) Hepatic radiofrequency under CT-fluoroscopy guidance. Radiol Med 113:87–100
Fahey BJ, Nelson RC, Hsu SJ, Bradway DP, Dumont DM, Trahey GE (2008) In vivo guidance and assessment of liver radio-frequency ablation with acoustic radiation force elastography. Ultrasound Med Biol 34:1590–1603
Ricke J, Wust P, Stohlmann A et al (2004) CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I–II results of a novel technique. Int J Radiat Oncol Biol Phys 58:1496–1505
Vogl TJ, Müller PK, Hammerstingl R, Weinhold N, Mack MG, Philipp C, Deimling M, Beuthan J, Pegios W, Riess H (1995) Malignant liver tumors treated with MR imaging-guided laser-induced thermotherapy: technique and prospective results. Radiology 196:257–265
Gaffke G, Gebauer B, Gnauck M, Knollmann FD, Helmberger T, Ricke J, Oettle H, Felix R, Stroszczynski C (2005) Potential advantages of the MRI for the radiofrequency ablation of liver tumors. Rofo 177:77–83
Puls R, Stroszczynski C, Gaffke G, Hosten N, Felix R, Speck U (2003) Laser-induced thermotherapy (LITT) of liver metastases: MR-guided percutaneous insertion of an MRI-compatible irrigated microcatheter system using a closed high-field unit. J Magn Reson Imaging 17:663–670
Wacker FK, Reither K, Ritz JP, Roggan A, Germer CT, Wolf KJ (2001) MR-guided interstitial laser-induced thermotherapy of hepatic metastasis combined with arterial blood flow reduction: technique and first clinical results in an open MR system. J Magn Reson Imaging 13:31–36
Reither K, Wacker F, Ritz JP, Isbert C, Germer CT, Roggan A, Wendt M, Wolf KJ (2000) Laser-induced thermotherapy (LITT) for liver metastasis in an open 0.2T MRI. Rofo 172:175–178
Huppert PE, Trübenbach J, Schick F, Pereira P, König C, Claussen CD (2000) MRI-guided percutaneous radiofrequency ablation of hepatic neoplasms—first technical and clinical experiences. Rofo 172:692–700
Lewin JS, Duerk JL, Jain VR, Petersilge CA, Chao CP, Haaga JR (1996) Needle localization in MR-guided biopsy and aspiration: effects of field strength, sequence design, and magnetic field orientation. Am J Roentgenol 166:1337–1345
Streitparth F, Gebauer B, Melcher I, Schaser K, Philipp C, Rump J, Hamm B, Teichgräber U (2009) MR-guided laser ablation of osteoid osteoma in an open high-field system (1.0 T). Cardiovasc Intervent Radiol 32:320–325
Gossmann A, Bangard C, Warm M, Schmutzler RK, Mallmann P, Lackner KJ (2008) Real-time MR-guided wire localization of breast lesions by using an open 1.0-T imager: initial experience. Radiology 247:535–542
Ricke J, Wust P, Wieners G et al (2004) Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation. J Vasc Interv Radiol 15:1279–1286
van Montfoort JE, Stieger B, Meijer DK, Weinmann HJ, Meier PJ, Fattinger KE (1999) Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1. J Pharmacol Exp Ther 290:153–157
Huppertz A, Balzer T, Blakeborough A et al (2004) Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 230:266–275
Zimmermann H, Müller S, Gutmann B, Bardenheuer H, Melzer A, Umathum R, Nitz W, Semmler W, Bock M (2006) Targeted-HASTE imaging with automated device tracking for MR-guided needle interventions in closed-bore MR systems. Magn Reson Med 56:481–488
Duerk JL, Wong EY, Lewin JS (2002) A brief review of hardware for catheter tracking in magnetic resonance imaging. MAGMA 13:199–208
Weiss CR, Nour SG, Lewin JS (2008) MR-guided biopsy: a review of current techniques and applications. J Magn Reson Imaging 27:311–325
Immel E, Melzer A (2006) Improvement of the MR imaging behavior of vascular implants. Minim Invasive Ther Allied Technol 15:85–92
Bock M, Wacker FK (2008) MR-guided intravascular interventions: techniques and applications. J Magn Reson Imaging 27:326–338
Weiss S, Vernickel P, Schaeffter T, Schulz V, Gleich B (2005) Transmission line for improved RF safety of interventional devices. Magn Reson Med 54:182–189
Busse H, Trampel R, Gründer W, Moche M, Kahn T (2007) Method for automatic localization of MR-visible markers using morphological image processing and conventional pulse sequences: feasibility for image-guided procedures. J Magn Reson Imaging 2:1087–1096
Will K, Schimpf F, Fischbach F, Ricke J, Schmidt B, Rose G (2010) Pre-tuned resonant marker for iMRI using aerosol deposition on polymer catheters. Proceedings of the SPIE medical imaging conference, 13–18 February 2010, San Diego
Mohnike K, Pech M, Seidensticker M, Rühl R, Wieners G, Gaffke G, Kropf S, Felix R, Wust P, Ricke J (2010) Computed-tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy and effect on survival. Int J Radiat Oncol Biol Phys. doi:10.1016/j.ijrobp.2009.07.1700
Ricke J, Mohnike K, Pech M, Seidensticker M, Rühl R, Wieners G, Gaffke G, Kropf S, Felix R, Wust P (2010) Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by CT-guided HDR-brachytherapy. Int J Radiat Oncol Biol Phys. doi:10.1016/j.ijrobp.2009.09.026
Buecker A, Spuentrup E, Schmitz-Rode T, Kinzel S, Pfeffer J, Hohl C, van Vaals JJ, Günther RW (2004) Use of a nonmetallic guide wire for magnetic resonance-guided coronary artery catheterization. Invest Radiol 39:656–660
Kos S, Huegli R, Hofmann E, Quick HH, Kuehl H, Aker S, Kaiser GM, Borm PJ, Jacob AL, Bilecen D (2009) Feasibility of real-time magnetic resonance-guided angioplasty and stenting of renal arteries in vitro and in swine, using a new polyetheretherketone-based magnetic resonance-compatible guidewire. Invest Radiol 44:234–241
Jungnickel K, Gaffke G, Lohfink K, Fischbach F, Bunke J, Will K, Ludewig M, Großer O, Omar A, Ricke J (2009) Evaluation of online thermometry during MR-guided intervention in a high field open system at 1.0 T. Int J CARS 4:S60–S61
Seror O, Lepetit-Coiffé M, Le Bail B, de Senneville BD, Trillaud H, Moonen C, Quesson B (2008) Real time monitoring of radiofrequency ablation based on MR thermometry and thermal dose in the pig liver in vivo. Eur Radiol 18:408–416
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ricke, J., Thormann, M., Ludewig, M. et al. MR-guided liver tumor ablation employing open high-field 1.0T MRI for image-guided brachytherapy. Eur Radiol 20, 1985–1993 (2010). https://doi.org/10.1007/s00330-010-1751-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-010-1751-5